Can engineered immune cells stop a rare muscle disease?
NCT ID NCT07752264
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This early-stage trial is testing whether a personalized cell therapy called Eque-cel can safely and effectively treat people with refractory immune-mediated necrotizing myopathy (IMNM), a severe autoimmune condition that causes muscle weakness and damage. The therapy involves reprogramming a patient's own immune cells to target and eliminate specific cells that drive the disease. The study will monitor side effects and measure improvements in muscle strength and function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Equecabtagene autoleucel (Eque-cel), a personalized CAR-T cell therapy that targets and eliminates BCMA-expressing cells to reset the immune system.
- What this could lead to
- If successful, this could lead to a new treatment option for people with refractory immune-mediated necrotizing myopathy, potentially offering long-term remission without lifelong immunosuppression.
- What could go wrong
- This is an early-phase, small trial (27 participants) focused on safety and initial efficacy. CAR-T therapies carry risks like cytokine release syndrome and neurological side effects, and the treatment may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY IMMUNE-MEDIATED NECROTIZING MYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
-
Huashan Hospital of Fudan University
Shanghai, Shanghai Municipality, 200040, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
-
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China